Related Experiment Video
Updated: Apr 26, 2026

Establishment and Maintenance of Patient-derived Prostate Cancer Organoids: A Detailed Experimental Protocol
Published on: November 14, 2025
[Organ and function preservation in prostate cancer].
1Klinik und Poliklinik für Urologie, Universitätsklinikum "Carl Gustav Carus" der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland, Michael.Froehner@uniklinikum-dresden.de.
New prostate cancer treatments aim to reduce overtreatment risks. However, many prostate-sparing or deferred options lack sufficient long-term data, making them largely experimental.
Area of Science:
- Oncology
- Urology
- Cancer Research
Context:
- Prostate cancer treatments carry risks impacting quality of life.
- Overdiagnosis of non-life-threatening prostate tumors leads to overtreatment.
- Current efforts focus on reducing overtreatment and its associated risks.
Purpose:
- To evaluate the current landscape of prostate cancer treatment options beyond traditional curative approaches.
- To assess the efficacy and safety of emerging prostate-sparing and deferred treatment strategies.
- To highlight the limitations in available data for novel prostate cancer interventions.
Summary:
- Curative prostate cancer treatments pose risks to quality of life.
- Several prostate-sparing or deferred treatment options are under investigation.
- Insufficient efficacy and safety data exist for many of these experimental approaches, including focal ablation and active surveillance.
- Active surveillance may be suitable for select patients with favorable risk profiles and high competing mortality risk.
Impact:
- Highlights the experimental nature of many novel prostate cancer treatments.
- Emphasizes the need for more long-term data to validate new therapeutic strategies.
- Informs clinical decision-making regarding prostate cancer management, particularly for elderly patients or those with comorbidities.
More Related Videos
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
08:36Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
Related Concept Videos
Kidney Transplant I: Introduction
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...